Cipla jumped 6.87% to Rs 566.10 at 10:47 IST on BSE on reports the company has launched an anti-asthma inhaler in Germany and Sweden that is a generic version of GlaxoSmithKline Plc's Advair.
Meanwhile, the S&P BSE Sensex was up 87.09 points or 0.32% at 26,954.64.
On BSE, so far 4.39 lakh shares were traded in the counter as against average daily volume of 1.89 lakh shares in the past two weeks.
The stock hit a high of Rs so 575.20 far during the day, which is a record high for the counter. The stock hit a low of Rs 532.10 so far during the day.
Cipla's consolidated net profit declined 39.3% to Rs 294.58 crore on 13.6% growth in net sales to Rs 2647.20 crore in Q1 June 2014 over Q1 June 2013.
Cipla is a global pharmaceutical company. Its portfolio includes 2000 products in 65 therapeutic categories with one quality standard globally.
Powered by Capital Market - Live News